SE

SARAH EGGE

SPLITOAK STRATEGIES LLC · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
14
last 3 years
Filings
43
5 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
1998-2000 Legislative Assistance to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011
Deputy Staff Director, Joint Select Committee on Deficit Reduction
Disclosed on LD-2 filings
Legislative Assistant to Senator Bob Kerrey
1998-2000); Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011
Disclosed on LD-2 filings
Legislative Assistant to Senator Bob Kerrey
1998-2000); Senior Budget analyst for Democratic Staff of the Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011
Disclosed on LD-2 filings
1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Kent Conrad); Fall 2011
Deputy Staff Director, Joint Select Committee for Deficit Reduction
Disclosed on LD-2 filings
1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Senator Kent Conrad); Fall 2011
Deputy Staff Director, Joint Select Committee on Deficit Reduction
Disclosed on LD-2 filings
Legislative Assistant
Sen. Bob Kerrey
1998-2000); Senior Budget Analyst, Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011
Disclosed on LD-2 filings
Legislative Assistant to Senator Bob Kerrey
1998-2000); Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Committee on Deficit Reduction (Fall 2011
Disclosed on LD-2 filings
Legislative Assistant to Senator Bob Kerrey; Senior Budget Analyst for Democratic staff of the Senate Budget Committee (Sen. Kent Conrad); Deputy Staff Director
Joint Select Committee on Deficit Reduction
Disclosed on LD-2 filings
1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Senator Kent Conrad); Fall 2011
Deputy Staff Director, Joint Select Committee on Deficit Reduction
Disclosed on LD-2 filings
1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011
Deputy Staff Director, Joint Select Committee on Deficit Reduction
Disclosed on LD-2 filings
Sarah: 1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Kent Conrad); Fall 2011
Deputy Staff Director, Joint Select Committee for Deficit Reduction
Disclosed on LD-2 filings
Legislative Assistant to Senator Bob Kerrey
1998-2000); Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (2001-2012); Deputy Staff Director\, Joint Select Committee on Deficit Reduction (Fall 2011
Disclosed on LD-2 filings
Legislative Assistant to Senator Bob Kerrey; Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Sen. Kent Conrad); Deputy Staff Director
Joint Select Committee on Deficit Reduction
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Extension of Priority Review Vouchers in S 4583; HR 7384 the Creating Hope Reauthorization Act, FDA reforms to improve rare disease patient perspective input and flexibilities
Health Issues · 2024 Q3
HR 5397 the Joe Fiandra Access to Home Infusion Act, HR 5526 Seniors' Access to Critical Medications Act; HR 8816 American Medical Innovation and Investment Act; Issues related to patient access to rare disease therapies
Medicare/Medicaid · 2024 Q3
Differentiate beer from cannabis; general policy regarding the regulation of the alcohol industry
Beverage Industry · 2024 Q3
Ensuring access to advanced genomic testing for cancer
Medical/Disease Research/Clinical Labs · 2024 Q3
Awareness of the need for access to all FDA-approved medications for treatment of substance use disorder; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments for substance use disorder and alcohol use disorder; Initiatives to promote the use of relapse prevention post detoxification; H.R.4531/S.3393 Support for Patients and Communities Reauthorization Act; Advance the use and funding of FDA-approved medicines to treat serious mental illness in criminal justice and public health settings
Health Issues · 2024 Q2
Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Proposed Rule (CMS-2434-P) -- and operational and patient access challenges with stacking policy
Medicare/Medicaid · 2024 Q2

Clients

$██,███ / qtrUnlock
2024 · 4 filings
$██,███ / qtrUnlock
2024 · 4 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock

Filing history

2024 Q3
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS
Q3lda.gov →
2024 Q3
UNITEDHEALTH GROUP
Q3lda.gov →
2024 Q3
CHIESI USA, INC.
Q3lda.gov →
2024 Q3
ADVANCED CARE AT HOME (ACH) COALITION
Q3lda.gov →
2024 Q2
ALKERMES, INC.
2Alda.gov →
2024 Q3
CARIS SCIENCE INC
Q3lda.gov →
2024 Q3
BIPARTISAN POLICY CENTER ACTION
Q3lda.gov →
2024 Q3
JOHNSON & JOHNSON SERVICES, INC.
Q3lda.gov →
2024 Q3
AMERICAN KIDNEY FUND
Q3lda.gov →
2024 Q3
ALNYLAM PHARMACEUTICALS, INC.
Q3lda.gov →
2024 Q3
ANHEUSER-BUSCH COMPANIES
Q3lda.gov →
2024 Q3
BRISTOL-MYERS SQUIBB
Q3lda.gov →
Showing recent filings · full history on lda.gov